Lionco Pharmaceutical Group (603669.SS) Earnings Analysis
Lionco Pharmaceutical Group (603669.SS) has no confirmed upcoming earnings date. Trailing P/E -21.57.
Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades
When does 603669.SS next report earnings?
No confirmed upcoming earnings date is currently scheduled for 603669.SS. This page updates as the calendar is published.
603669.SS earnings history — beats and misses
| Quarter (report date) | EPS actual | EPS est. | Surprise | Result |
|---|---|---|---|---|
| 2025-06-30 | -0.02757 CNY | n/a | n/a | n/a |
| 2025-04-25 | -0.03 CNY | n/a | n/a | n/a |
| 2025-04-18 | -0.11629 CNY | n/a | n/a | n/a |
| 2024-10-30 | -0.009 CNY | n/a | n/a | n/a |
| 2024-08-23 | -0.03377 CNY | n/a | n/a | n/a |
603669.SS valuation and analyst view
| Trailing P/E | -21.57 |
|---|---|
| Trailing EPS | -0.244 CNY |
| Price / book | 5.97 |
| Dividend yield | 0.00% |
| Market cap | 3.88B |
Limited or no published sell-side analyst coverage for this symbol.
Related research pages
Frequently asked questions
When is Lionco Pharmaceutical Group (603669.SS)'s next earnings date?
No confirmed upcoming earnings date is currently scheduled for 603669.SS. This page updates as the calendar is published.
Did 603669.SS beat earnings last quarter?
Consensus estimate data was not available for 603669.SS's 2025-06-30 report.
What is 603669.SS's current P/E ratio and EPS?
603669.SS trades at a trailing P/E of -21.57 on trailing EPS of -0.24399629065029665 CNY.
What do analysts rate 603669.SS?
603669.SS has limited or no published sell-side analyst coverage in our dataset, so no consensus rating is shown. Fundamentals and earnings history above are sourced from company filings via FMP.